Azbil Corporation has been issued with an A+ rating from ‘Rating and Investment Information, Inc.’ The reason for the rating upgrade lies in that stable earnings sources, such as maintenance services, have been expanding, allowing the company to generate solid profits even under substantial stress. The credit rating agency has upgraded the issuer rating from A to A+, positively evaluating progress in strengthening the earnings base. Azbil’s financial base itself, including factors such as a good debt-equity structure and good balance between debt and cash flow, was also rated highly.
Obtaining an “A+” rating is seen as one of the results of the company’s efforts toward sustainable growth.
Download complete information here
El equipo de investigadores observó cambios en el...
El gen AtCDF3 promueve una mayor producción de az...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del si...
Una investigación liderada por científicos del IIBB-CSIC y del CIBER...
Portal de biotecnología en España
¡Suscríbase a nuestro newsletter para estar al día con las últimas noticias y ofertas!
2013 © Biotech-Spain.com - Site Developments SL. Todos los derechos reservados. Terminos y Condiciones | Política de Privacidad
Articles
Directory